Phase 2b RCT | Liposomal irinotecan plus fluorouracil/leucovorin for patients with previously treated metastatic biliary tract cancer

Treatment With Liposomal Irinotecan Plus Fluorouracil and Leucovorin for Patients With Previously Treated Metastatic Biliary Tract Cancer: The Phase 2b NIFTY Randomized Clinical Trial – JAMA Oncology (link to abstract – $ for full-text)

Commentary on Twitter

Final analysis of NIFTY trial demonstrates significant improvement of PFS & OS with use of nal-IRI plus 5-FU/LV compared to 5-FU/LV in patients with previously treated advanced biliary tract cancer. https://t.co/WrZ3GtXYxP #GICSM pic.twitter.com/BqxSbBG9dv

— JAMA Oncology (@JAMAOnc) March 23, 2023